SAS and Posit Join Forces to Enhance AI in Life Sciences with Open Source Technologies

SAS and Posit Partner to Transform Life Sciences with AI



SAS, recognized globally as a frontrunner in data analytics and AI solutions, has announced a strategic partnership with Posit PBC, formerly known as RStudio. This collaboration is set to empower organizations in the life sciences sector by providing greater flexibility in utilizing both SAS and open-source technologies, particularly in the realm of clinical development.

Integration of Technologies



The focus of this partnership is to seamlessly integrate SAS's own platforms, particularly SAS® Viya® and SAS® Clinical Acceleration, with Posit’s suite of tools, such as Posit Workbench, Positron, Posit Connect, and Posit Package Manager. By combining SAS's robust analytics and governance capabilities with Posit’s open-source offerings, this collaboration aims to create a comprehensive environment that meets the complex regulatory requirements essential for clinical research.

Mark Lambrecht, the Global Head of Health Care and Life Sciences Solutions at SAS, expressed enthusiasm about the collaboration. He noted, "Life sciences organizations can now bring together the flexibility of open source with the rigor required for regulated clinical research," highlighting the dual advantage of innovation and compliance.

Empowering Clinical Teams



One of the standout features of this partnership is its capacity to support teams working on clinical trials. With SAS’s Clinical Acceleration, users gain access to a secure clinical data repository and an AI-assisted statistical environment designed to ready clinical research for regulatory submission. Posit's integration promises users a secure and structured method to incorporate open-source technologies within enterprise settings.

Eric Pite, Senior Vice President of Product and Strategy at Posit, mentioned the challenges faced by clinical teams in integrating different programming languages when working with SAS and R. He stated, "Clinical teams have asked us for a way to use R and Python without giving up the controls they rely on in SAS." The new capabilities allow programmers to write both SAS and R code concurrently using Posit tools, creating efficiency and reducing the complexity of data management.

Features of the Partnership



The integration allows teams to operate within managed, versioned R environments while controlling dependencies and ensuring interoperability with SAS Clinical Acceleration. This teamed approach provides data scientists and developers with a streamlined experience across multiple programming languages, including SAS, R, Python, and SQL. The inclusion of tools like Positron and Posit Assistant enables code development in a collaborative manner while the Posit Package Manager ensures consistency in the R and Python environments.

As noted by Dilip Raghunathan, Business Solutions Partner at Regeneron, the prior necessity for workarounds and duplicated access control governance can now be eliminated. He articulated, "Now our programmers write both in one session under their own access rights, with AI assistance that works within those same controls, allowing us to tackle complex multilingual workflows seamlessly."

Meet SAS and Posit at PHUSE EU Connect



This innovative collaboration will be on display at the upcoming PHUSE EU Connect event held in Glasgow from November 15 to 18, where experts from both SAS and Posit will be present. Attendees are encouraged to visit the SAS booth (P3) and the Posit booth (43) to learn more about these pioneering advancements.

About SAS



For decades, SAS has set the gold standard in data analytics and AI, providing organizations with the tools necessary to make confident, data-driven decisions. Their commitment to transparency, governance, and industry expertise establishes them as trusted leaders in the data science domain.

About Posit



Posit, PBC is dedicated to fostering robust data analyses that are correct, transparent, and reproducible. Their products are utilized by thousands of organizations around the world, ranging from small startups to Fortune 500 companies. Their mission is to leverage software to enhance decision-making capabilities through data, ensuring that human and AI collaboration yields the best results.

Overall, the partnership between SAS and Posit marks a significant step toward enhancing the integration of AI in life sciences, paving the way for innovative solutions that cater to the rigorous demands of clinical research, thus benefiting the industry at large.

Topics Business Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.